The Cholestasis drugs in development market research report provides comprehensive information on the therapeutics under development for Cholestasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Cholestasis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Cholestasis and features dormant and discontinued products.
GlobalData tracks 17 drugs in development for Cholestasis by 17 companies/universities/institutes. The top development phase for Cholestasis is preclinical with nine drugs in that stage. The Cholestasis pipeline has 15 drugs in development by companies and two by universities/ institutes. Some of the companies in the Cholestasis pipeline products market are: Takeda Pharmaceutical, Vivet Therapeutics and Ipsen.
The key targets in the Cholestasis pipeline products market include Ileal Sodium/Bile Acid Cotransporter, Bile Acid Receptor, and Bile Salt Export Pump.
The key mechanisms of action in the Cholestasis pipeline product include Ileal Sodium/Bile Acid Cotransporter Inhibitor with three drugs in Pre-Registration. The Cholestasis pipeline products include three routes of administration with the top ROA being Oral and three key molecule types in the Cholestasis pipeline products market including Small Molecule, and Gene Therapy.
Cholestasis overview
Cholestasis is the slowing or stalling of bile flow from liver. Liver produces bile and delivers it to digestive system through a network of vessels called bile ducts. Bile ducts run through liver (intrahepatic ducts) as well as outside of it (extrahepatic ducts). They connect liver, gallbladder, pancreas and small intestine. Bile that can’t reach your intestines can also cause problems in your digestive system.
For a complete picture of Cholestasis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
